IgG4-related Disease Clinical Trials in Wuhan, Hubei
2 recruitingWuhan, Hubei, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497361
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497387